Loading…
Nuvectis Pharma, Inc. is projected to rise to $16.81 by 2027, a +66% move from its current price of $10.15. NVCT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.75 | $10.16 | $10.58 | +0.07% |
| May 30 | $9.60 | $10.16 | $10.77 | +0.14% |
| May 31 | $9.48 | $10.17 | $10.92 | +0.22% |
| Jun 1 | $9.38 | $10.18 | $11.04 | +0.29% |
| Jun 2 | $9.30 | $10.19 | $11.16 | +0.36% |
| Jun 3 | $9.22 | $10.19 | $11.26 | +0.43% |
| Jun 4 | $9.16 | $10.20 | $11.36 | +0.51% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.16 | $10.20 | $11.36 | +0.51% |
| Week 2 | $8.80 | $10.25 | $11.94 | +1.01% |
| Week 3 | $8.55 | $10.30 | $12.42 | +1.53% |
| Week 4 | $8.35 | $10.36 | $12.85 | +2.04% |
| Week 5 | $8.18 | $10.41 | $13.25 | +2.55% |
| Week 6 | $8.03 | $10.46 | $13.63 | +3.07% |
| Week 7 | $7.90 | $10.51 | $13.99 | +3.59% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company in Healthcare. It focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.
The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc.
in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
NVCT is trading at $10.35 with a market cap of $274.54M. It is ranked 3602. The forecast portrays a path of higher prices over the coming years, with an average price rising from the current level toward substantial gains by 2030 and extending into the 2040s and 2050s.
By 2030 the average price is $29.39 and by 2050 the average price is $208.77, with notable max values along the way.
A major floor 39.0% below — a decisive break under it would weaken the trend.
The nearest floor, 17.9% below — buyers have tended to step in here.
The nearest ceiling, 22.7% above — a clean break opens room to run.
A major ceiling 42.2% above — clearing it would confirm fresh momentum.
Key NVCT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NVCT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.43 | Sell | $10.36 | Sell |
| MA 10 | $10.84 | Sell | $10.49 | Sell |
| MA 20 | $10.33 | Sell | $10.25 | Sell |
| MA 50 | $9.07 | Buy | $9.52 | Buy |
| MA 100 | $8.88 | Buy | $8.89 | Buy |
| MA 200 | $7.67 | Buy | $8.30 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.11 | Neutral |
| Stoch RSI (14) | 1.42 | Buy |
| CCI (20) | -14.36 | Neutral |
| Williams %R (14) | -97.87 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -12.88 | Sell |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 2.13 | Buy |
| TRIX (15) | 0.92 | Buy |
| Awesome (5,34) | 0.82 | Buy |
| Ultimate (7,14,28) | 40.21 | Neutral |
| Momentum (10) | -0.75 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 10.15 | Sell |
| ADX (14) | 19.56 | Neutral |
| ATR (14) | 0.40 | Info |
The 30-day technical picture shows bullish sentiment overall. RSI13 is 50, indicating a neutral tilt within a bullish context. The 50-day simple moving average is $9.03 and the 200-day simple moving average is $7.63. Support is at $8.33 and resistance at $12.45, framing the near-term path.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.48 | $10.15 | $14.88 | 0% | Neutral | |
| $12.69 | $16.81 | $23.91 | +66% | Bullish | |
| $14.44 | $19.96 | $29.83 | +97% | Bullish | |
| $16.23 | $23.27 | $36.16 | +129% | Bullish | |
| $17.92 | $26.55 | $42.62 | +162% | Bullish | |
| $18.00 | $27.48 | $45.39 | +171% | Bullish | |
| $18.63 | $29.27 | $49.58 | +188% | Bullish | |
| $21.29 | $34.37 | $59.56 | +239% | Bullish | |
| $28.82 | $47.77 | $84.51 | +371% | Bullish | |
| $32.41 | $55.09 | $99.37 | +443% | Bullish | |
| $41.78 | $79.94 | $156.21 | +688% | Bullish | |
| $77.87 | $173.05 | $379.09 | +16.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $7.48 | $10.15 | $12.01 | +0.00% |
| June 2026 | $8.99 | $10.67 | $13.05 | +5.11% |
| July 2026 | $9.02 | $10.84 | $13.52 | +1.60% |
| August 2026 | $8.57 | $10.40 | $13.18 | -4.01% |
| September 2026 | $8.66 | $10.60 | $13.59 | +1.91% |
| October 2026 | $9.20 | $11.35 | $14.71 | +7.02% |
| November 2026 | $9.18 | $11.41 | $14.93 | +0.54% |
| December 2026 | $9.02 | $11.27 | $14.88 | -1.21% |
Click any year to see its month-by-month NVCT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NVCT price prediction for 2026 points to an average of $10.15 (low $7.48, high $14.88) — a potential gain of 0% on today's $10.15. Price action looks broadly range-bound.
In 2027, NVCT is projected to trade between $12.69 and $23.91, averaging $16.81 — a potential gain of +66% from today's $10.15. That is up +66% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Nuvectis Pharma, Inc.'s 2028 outlook centres on $19.96, within a $14.44 to $29.83 range. That is up +19% on the projected 2027 average. That marks a +97% change versus current levels. Momentum favours further upside here.
By 2029, NVCT could reach as high as $36.16, with a base case around $23.27 and support toward $16.23 — roughly +129% from $10.15. Buyers look set to stay in control over this stretch.
Expect NVCT to range from $17.92 to $42.62 through 2030. The $26.55 average target implies a +162% move from current prices. That is up +14% on the projected 2029 average. Momentum favours further upside here.
The NVCT price prediction for 2031 points to an average of $27.48 (low $18.00, high $45.39) — a potential gain of +171% on today's $10.15. Buyers look set to stay in control over this stretch.
In 2032, NVCT is projected to trade between $18.63 and $49.58, averaging $29.27 — a potential gain of +188% from today's $10.15. That is up +7% on the projected 2031 average. Momentum favours further upside here.
Nuvectis Pharma, Inc.'s 2033 outlook centres on $34.37, within a $21.29 to $59.56 range. That is up +17% on the projected 2032 average. That marks a +239% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, NVCT could reach as high as $84.51, with a base case around $47.77 and support toward $28.82 — roughly +371% from $10.15. Momentum favours further upside here.
Expect NVCT to range from $32.41 to $99.37 through 2035. The $55.09 average target implies a +443% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The NVCT price prediction for 2040 points to an average of $79.94 (low $41.78, high $156.21) — a potential gain of +688% on today's $10.15. Momentum favours further upside here.
In 2050, NVCT is projected to trade between $77.87 and $379.09, averaging $173.05 — a potential gain of +16.0x from today's $10.15. That is up +116% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NVCT today (≈ 98.522167 NVCT) could be worth
$17,048.87
+$16,048.87 (+1605%) by 2050 · US Dollar
Based on the average projected NVCT price of $173.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NVCTwould be worth at today's price.
$1,000 invested in NVCT on May 27, 2025 (≈ 103.51967 NVCT) would be worth
$1,050.72
+$50.72 (+5.1%) today · 1.05× · US Dollar
Based on a NVCT entry price of $9.66 vs. today's $10.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.63 | $954.84 | -4.5% |
| 1 month ago | $8.75 | $1,160 | +16.0% |
| 3 months ago | $8.94 | $1,135.35 | +13.5% |
| 6 months ago | $6.24 | $1,626.6 | +62.7% |
| 1 year ago | $9.66 | $1,050.72 | +5.1% |
| All time (4.3y) ago | $3.25 | $3,123.08 | +212.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NVCT forecast.
Our base-case forecast reaches $20.00 around 2029.
Implied market cap at $20.00: $530.51M
The multi-year forecast outlines a bullish trajectory with rising averages and strong upside potential. In 2030, the average price is $29.39 with a range from $19.52 to $47.93, and ROI 184, in a bullish context. In 2040, the average price is $94.63 with a range from $47.63 to $189.08, and ROI 814.3.
In 2050, the average price is $208.77 with a range from $93.94 to $469.25, and ROI 1917.1. These figures reflect the long-run upward potential while acknowledging uncertainty and that these are estimates, not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $29.39 with a range from $19.52 to $47.93, and ROI 184; sentiment BULLISH.
The forecast shows bullish sentiment in 2027–2050 with rising averages (e.g., $18.15 in 2027, $21.33 in 2028, $25.31 in 2029) and increasing ROI (e.g., 75.3 in 2027, 106.1 in 2028, 144.6 in 2029). These are estimates and not guarantees.
Yes. The 2040 max is $189.08, which is above $100, indicating the possibility of surpassing that level by 2040.
Current price is $10.35 and market cap is $274.54M.
In 2050, the average price is $208.77 with a range from $93.94 to $469.25, and ROI 1917.1; sentiment BULLISH.
Nuvectis Pharma, Inc. Community Discussion
0Share your Nuvectis Pharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.